Awareness and beliefs about FDA e-cigarette regulation in the premarket application review era
Addictive Behaviors · 2023
DOI: 10.1016/j.addbeh.2023.107748 ↗Kurz gefasst
Fachartikel in der Zeitschrift Addictive Behaviors, 2023. Verfasst von Caitlin Weiger und 4 weiteren Autor:innen. Beteiligte Einrichtung: Rutgers Center for Tobacco Studies, Rutgers University, New Brunswick, NJ, United States. Electronic address: caitlin.weiger@rutgers.edu. Hauptthemen laut MEDLINE: Electronic Nicotine Delivery Systems, Tobacco Products. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
INTRODUCTION: In March 2022, FDA granted its first marketing orders for e-cigarettes. Few studies have assessed awareness of FDA e-cigarette regulation and authorization in the era of premarket review. This study describes prevalence of awareness as well as beliefs about regulation among adults who smoke and youth. METHODS: We conducted a cross-sectional, nationally representative online survey of 866 adults who currently smoke cigarettes and 859 youth (ages 15-20) in June 2022 using Ipsos KnowledgePanel. Population prevalence of regulatory awareness and beliefs are reported. Pearson χ2 and multivariable logistic regressions were conducted to assess dependent and independent associations with demographic and tobacco use characteristics. RESULTS: Awareness that FDA regulates e-cigarettes was low among adults who smoke (25.4 %) and youth (18.5 %). Awareness that FDA authorizes e-cigarettes was also low among adults who smoke (10.8 %) and youth (12.7 %). Agreement with both positive and negative beliefs regarding FDA e-cigarette regulation was below 50 %. Current e-cigarette use was significantly associated with agreeing that regulation: makes e-cigarettes safer (adult aOR: 2.90, youth aOR: 2.51), helps prevent youth initiation (adult aOR 1.92), takes away freedom to choose to use e-cigarettes (adult aOR: 3.02, youth aOR: 2.58), and limits types of e-cigarettes available (adult aOR: 2.22, youth aOR: 2.49). DISCUSSION: There is low awareness of FDA e-cigarette regulation and authorization and relatively low agreement with positive beliefs about e-cigarette regulation. Further study is needed to assess how the changing regulatory environment impacts product perceptions, intentions, and behaviors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Rutgers Center for Tobacco Studies, Rutgers University, New Brunswick, NJ, United States. Electronic address: caitlin.weiger@rutgers.edu.
- Rutgers Center for Tobacco Studies, Rutgers University, New Brunswick, NJ, United States; Department of Health Behavior, Society, and Policy, Rutgers School of Public Health, Piscataway, NJ, United States; Rutgers Cance…
Förderung
- NCI NIH HHS
Zitieren
APA
Weiger, C., Chen-Sankey, J., Jeong, M., Delnevo, C., & Wackowski, O. (2023). Awareness and beliefs about FDA e-cigarette regulation in the premarket application review era. Addictive Behaviors. https://doi.org/10.1016/j.addbeh.2023.107748
Vancouver
Weiger C, Chen-Sankey J, Jeong M, Delnevo C, Wackowski O. Awareness and beliefs about FDA e-cigarette regulation in the premarket application review era. Addictive Behaviors. 2023. doi:10.1016/j.addbeh.2023.107748
BibTeX
@article{Weiger2023,
author = {Weiger, Caitlin and Chen-Sankey, Julia and Jeong, Michelle and Delnevo, Cristine and Wackowski, Olivia},
title = {Awareness and beliefs about FDA e-cigarette regulation in the premarket application review era},
journal = {Addictive Behaviors},
year = {2023},
doi = {10.1016/j.addbeh.2023.107748}
}
EUVIMED